Comparative analysis of homocysteine concentrations in patients with retinal vein occlusion versus thrombotic and atherosclerotic disorders
Natural anticoagulants and fibrinolytic activity following interferon therapy in chronic viral hepatitis
Race and sex differences in thrombogenicity: risk of ischemic events following coronary stenting
Evaluation of thromboelastography for monitoring recombinant activated factor VII ex vivo in haemophilia A and B patients with inhibitors: a multicentre trial
Clot life span model analysis of clot growth and fibrinolysis in normal subjects: role of thrombin activatable fibrinolysis inhibitor
Influence of direct thrombin inhibitor argatroban on coagulation assays in healthy individuals, patients under oral anticoagulation therapy and patients with liver dysfunction
Thrombosis in children with cardiac pathology: analysis of acquired and inherited risk factors
Caspase inhibition of platelet activation
Fenofibrate improves endothelial function and decreases thrombin-activatable fibrinolysis inhibitor concentration in metabolic syndrome
Consolidation treatment with rituximab induces complete and persistent remission of mixed type Evans syndrome
Cardioverter-defibrillator lead-related thrombus treated with prolonged anticoagulation in patient with prothrombotic disorder
Desmoteplase-mediated plasminogen activation and clot lysis are inhibited by the lysine analogue tranexamic acid
Aspirin resistance in patients with coronary artery disease – which test to use in routine management?
Patent foramen ovale and prothrombotic markers in young stroke patients
Adjunctive role for recombinant activated factor VII in the treatment of bleeding secondary to a factor V inhibitor
The role of cellular microparticles in platelet-related hemostasis measured using Platelet Function Analyzer-100
Dishomogeneous separation of citrated plasma in primary collection tubes for routine coagulation testing